Wang Y, Zheng X, Yang Y, Zhao X, Li M, Huang J
Front Microbiol. 2025; 16:1559840.
PMID: 40078537
PMC: 11897277.
DOI: 10.3389/fmicb.2025.1559840.
Volz A, Clever S, Tscherne A, Freudenstein A, Jany S, Schwarz J
NPJ Vaccines. 2025; 10(1):44.
PMID: 40044709
PMC: 11882785.
DOI: 10.1038/s41541-025-01094-0.
Wullimann D, Sandberg J, Akber M, Lofling M, Gredmark-Russ S, Michaelsson J
PLoS Negl Trop Dis. 2025; 19(2):e0012693.
PMID: 40019865
PMC: 11893121.
DOI: 10.1371/journal.pntd.0012693.
Grabski H, Grabska S, Abagyan R
Viruses. 2025; 17(1).
PMID: 39861795
PMC: 11769402.
DOI: 10.3390/v17010006.
Stegeman S, Kourko O, Amsden H, Pellizzari Delano I, Mamatis J, Roth M
J Innate Immun. 2025; 17(1):126-153.
PMID: 39820070
PMC: 11845175.
DOI: 10.1159/000543608.
Role of extracellular vesicles in the pathogenesis of mosquito-borne flaviviruses that impact public health.
Martinez-Rojas P, Monroy-Martinez V, Ruiz-Ordaz B
J Biomed Sci. 2025; 32(1):4.
PMID: 39754219
PMC: 11699717.
DOI: 10.1186/s12929-024-01096-5.
Dynamics of immune responses following duck Tembusu virus infection in adult laying ducks reveal the effect of age-related immune variation on disease severity.
Nedumpun T, Rungprasert K, Ninvilai P, Limcharoen B, Tunterak W, Prakairungnamthip D
Poult Sci. 2024; 104(2):104731.
PMID: 39740493
PMC: 11750524.
DOI: 10.1016/j.psj.2024.104731.
Dengue Virus Infection: Immune Response and Therapeutic Targets.
Tin Ern N, Komarasamy T, Adnan N, Balasubramaniam V
Am J Trop Med Hyg. 2024; 112(1):37-44.
PMID: 39531732
PMC: 11720763.
DOI: 10.4269/ajtmh.23-0545.
Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidate.
Porier D, Adam A, Kang L, Michalak P, Tupik J, Santos M
PLoS Pathog. 2024; 20(10):e1012566.
PMID: 39388457
PMC: 11495591.
DOI: 10.1371/journal.ppat.1012566.
Unraveling flavivirus pathogenesis: from bulk to single-cell RNA-sequencing strategies.
Kim D, Jeong S, Park S
Korean J Physiol Pharmacol. 2024; 28(5):403-411.
PMID: 39198221
PMC: 11362000.
DOI: 10.4196/kjpp.2024.28.5.403.
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins.
Aregay A, Slunecko J, Korva M, Bogovic P, Rus K, Knap N
NPJ Vaccines. 2024; 9(1):141.
PMID: 39112523
PMC: 11306791.
DOI: 10.1038/s41541-024-00936-7.
Comprehensive analysis of early T cell responses to acute Zika Virus infection during the first epidemic in Bahia, Brazil.
Samri A, Bandeira A, Gois L, Silva C, Rousseau A, Corneau A
PLoS One. 2024; 19(5):e0302684.
PMID: 38722858
PMC: 11081376.
DOI: 10.1371/journal.pone.0302684.
Japanese encephalitis virus NS1 and NS1' proteins induce vimentin rearrangement via the CDK1-PLK1 axis to promote viral replication.
Xie S, Yang X, Yang X, Cao Z, Wei N, Lin X
J Virol. 2024; 98(5):e0019524.
PMID: 38656209
PMC: 11092344.
DOI: 10.1128/jvi.00195-24.
Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity.
Fan Y, Chen J, Chen Y, Ke Y, Chang G, Chiou S
J Virol. 2024; 98(4):e0177323.
PMID: 38530012
PMC: 11019926.
DOI: 10.1128/jvi.01773-23.
Recapitulation of the Powassan virus life cycle in cell culture.
Song J, Hong J, Yang C, Zhang Y, Li Z, He P
mBio. 2024; 15(4):e0346823.
PMID: 38411112
PMC: 11005349.
DOI: 10.1128/mbio.03468-23.
Inapparent Tick-Borne Orthoflavivirus Infection in : A Model for Antiviral Drug and Vaccine Research.
Illarionova V, Rogova A, Tuchynskaya K, Volok V, Rogova Y, Baryshnikova V
Vaccines (Basel). 2023; 11(12).
PMID: 38140159
PMC: 10747564.
DOI: 10.3390/vaccines11121754.
Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections.
Rossbacher L, Malafa S, Huber K, Thaler M, Aberle S, Aberle J
J Med Virol. 2023; 95(11):e29245.
PMID: 38009693
PMC: 10952712.
DOI: 10.1002/jmv.29245.
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.
Ormundo L, Barreto C, Tsuruta L
Viruses. 2023; 15(11).
PMID: 38005854
PMC: 10675117.
DOI: 10.3390/v15112177.
Oligodendrocyte-derived IL-33 functions as a microglial survival factor during neuroinvasive flavivirus infection.
Norris G, Ames J, Ziegler S, Oberst A
PLoS Pathog. 2023; 19(11):e1011350.
PMID: 37983247
PMC: 10695366.
DOI: 10.1371/journal.ppat.1011350.
A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.
Kuhn R, Barrett A, DeSilva A, Harris E, Kramer L, Montgomery R
J Infect Dis. 2023; 228(Suppl 6):S398-S413.
PMID: 37849402
PMC: 10582523.
DOI: 10.1093/infdis/jiad193.